Click to slide down
Home » Grow » Sector Growth » Ambitious Essex Tech 50 » isogenica
About the Company: Founded over 25 years ago and based in Saffron Walden, Isogenica is a biotechnology contract research organization (CRO) specializing in the discovery and engineering of small-format, single-domain antibodies (VHH). These antibodies offer exceptional robustness, flexibility, and scalability across various therapeutic and diagnostic applications.
Services and Products: Isogenica focuses on VHH single-domain antibodies, which are derived from camelids and are now recognized as a next-generation antibody therapeutic format. The company combines the largest and most diverse synthetic VHH libraries with proprietary, cell-free CIS display technology. This approach allows Isogenica to deliver high-quality antibody solutions in about half the time of traditional immunization methods. Their services include tailored antibody discovery projects, providing industry-disrupting solutions for partners in the biopharma sector
Mission and Values: Isogenica’s mission is to advance the field of antibody research by delivering precise, high-quality results for their clients. The company values innovation, collaboration, and scientific excellence, aiming to push the boundaries of antibody discovery and engineering.
Key Strengths:
Isogenica continues to lead the way in antibody discovery and engineering, offering innovative solutions that drive advancements in therapeutic and diagnostic applications.
Visit isogenica